### U.S. Environmental Protection Agency Office of Prevention, Pesticides, and Toxic Substances (OPPTS) 1200 Pennsylvania Avenue, N.W. Washington, D.C. 20460

OPPTS-RCS-OMB-7f (revised 09/23/2009) If you have any questions about this regulatory action or this documentation, please call the contact: Name: eMail: Phone: 

### Title of Action:



## Documentation of Changes Made During OMB Review Under Executive Order 12866

Docket #: EPA-HQ- FRL#: RIN: 2070-

This action was submitted to the Office of Management and Budget (OMB) for review under Executive Order 12866, entitled Regulatory Planning and Review (58 FR 51735, October 4, 1993). According to section 6(a)(3)(E) of the Executive Order, whenever the Agency makes publicly available a regulatory action that was reviewed under Executive Order 12866, the Agency is also required to:

(1) Make available to the public a copy of the information that was provided to OMB's Office of Information and Regulatory Affairs (OIRA) for review under the Executive Order, i.e., the text of the draft regulatory action and, if applicable, an assessment of the potential costs and benefits; as well as additional information required for those actions that are determined to be economically significant under section 3(f) of the Executive Order (see section 6(a)(3)(B) & (C)); (2) Identify for the public any substantive changes between the draft submitted to OMB and the action that was subsequently issued, using a method that is complete, clear and simple; and (3) Identify for the public those substantive changes made at the suggestion or recommendation of OIRA/OMB. 

### For this regulatory action, were substantive changes made to the regulatory action reviewed under Executive Order 12866? [Please check the appropriate answer.] Yes. [The information identified in items 1-3 below is included in the docket, as applicble.] No. [Only the information identified in item 1 below is included in the docket.] 

### Accordingly, the Agency has included the following information in the public docket for this regulatory action: [Please check the appropriate box(s).] (2) Documentation of any substantive changes that were made to the draft regulatory text that was submitted to OIRA/OMB for review, when compared with what subsequently published, using one of the following methods (select one): (1) A copy of the information that was provided to OIRA for review under the Executive Order.

(3) Documentation of those substantive changes made at the suggestion or recommendation of OMB , if any, are identified in the document using one of the following methods (select one): (a) A copy of the draft regulatory action submitted, with redline and strikeout to show all the substantive changes that were made. (b) A document that identifies the substantive changes that were made, with page and paragraph references to the draft regulatory action that was submitted.

(a) Through attributions to OMB in the redline and strikeout version or other document identifying the changes made at OMB's recommendation. (c) Other (please describe):

(b) Other (please describe):

Angela Hofmann Hofmann.Angela@epa.gov 202-564-0258 

### Hexabromocyclododecane (HBCD) Action Plan; Informal Review of Non-Rule OPPT-2010-0550 n/a ZA10

Comments received were identified as "Interagency Comments" without attribution.